(19)
(11) EP 2 329 835 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
11.09.2013 Bulletin 2013/37

(45) Mention of the grant of the patent:
31.07.2013 Bulletin 2013/31

(21) Application number: 11000805.9

(22) Date of filing: 12.08.2003
(51) International Patent Classification (IPC): 
A61K 36/00(2006.01)

(54)

Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease

Zusammensetzung mit dem Extrakt von Actinidia arguta und verwandter Spezies zur Vorbeugung und Behandlung allergischer Erkrankungen und nicht allergischer entzündlicher Erkrankungen

Composition à base d'extrait d'actinidia arguta et espèces connexes, destinée au traitement et à la prévention d'affections allergiques et d'affections non allergiques inflammatoires

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 23.08.2002 US 405295 P

(43) Date of publication of application:
08.06.2011 Bulletin 2011/23

(62) Application number of the earlier application in accordance with Art. 76 EPC:
03792857.9 / 1551433

(73) Proprietor: Viromed Co., Ltd.
Seoul 151-747 (KR)

(72) Inventors:
  • Kim, Bongcheol
    Gwacheon-si Kyonggi-do 427-802 (KR)
  • Jin, Mirim
    Songpa-gu Seoul 138-050 (KR)
  • Park, Eun-Jin
    Yongdungpo-gu Seoul 150-754 (KR)
  • Jung, Hyung-Jin
    Seongdong-gu Seoul 133-880 (KR)
  • Shin, Sung-Seup
    Kangnam-gu Seoul 135-520 (KR)
  • Oh, Jin-Hwan
    Suwon-si Kyonggi-do 440-705 (KR)
  • Lee, Hwa-Jun
    Sungdong-gu Seoul 133-070 (KR)
  • Kim, Sunyoung
    Pocheon-si Gyeonggi-do 487-821 (KR)
  • Jeong, Hyang
    Kangnam-gu Seoul 135-966 (KR)

(74) Representative: Schnappauf, Georg et al
Dr. Volker Vossius Patentanwälte / Partnerschaftsgesellschaft Radlkoferstrasse 2
81373 München
81373 München (DE)


(56) References cited: : 
DE-A1- 19 758 090
   
  • KIM YOO KYUNG ET AL: "Anti-inflammation activity of Actinidia polygama.", ARCHIVES OF PHARMACAL RESEARCH DEC 2003, vol. 26, no. 12, December 2003 (2003-12), pages 1061-1066, XP002528453, ISSN: 0253-6269
  • MOTOHASHI N ET AL: "Biological activity of kiwifruit peel extracts", PHYTOTHERAPY RESEARCH 2001 GB, vol. 15, no. 4, 2001, pages 337-343, XP002528455, ISSN: 0951-418X
  • CHEONG H ET AL: "Studies of structure activity relationship of flavonoids for the anti-allergic actions", ARCHIVES OF PHARMACAL RESEARCH, NATL. FISHERIES UNIVERSITY, PUSAN, KR, vol. 21, no. 4, 1 January 1998 (1998-01-01), pages 478-480, XP002994940, ISSN: 0253-6269
  • LUGASI A ET AL: "Flavonoid aglycons in foods of plant origin II. Fresh and dried fruits", ACTA ALIMENTARIA, AKADEMIAI KRADO. BUDAPEST, HU, vol. 31, no. 1, 1 January 2002 (2002-01-01), pages 63-71, XP002968849, ISSN: 0139-3006, DOI: DOI:10.1556/AALIM.31.2002.1.6
  • KIMATA MASAHIRO ET AL: "Effects of luteolin and other flavonoids on IgE-mediated allergic reactions", PLANTA MEDICA, vol. 66, no. 1, February 2000 (2000-02), pages 25-29, XP002629315, ISSN: 0032-0943
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).